Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

French athlete handed six-month ban for doping
eventing
Livio and the French eventing team lost their slot in the Rio 2016 Olympic Games after the horse tested positive for a banned substance. (stock image)
Sanctions follow failed drugs test

French eventer Maxime Livio has been handed a fine and banned for six months after horse Qalao des Mers tested positive for a controlled medication substance.

A sample taken from the horse on 29 August last year tested positive for hydroxyethylpromazine sulfoxide, which is a metabolite of acepromazine.

After the findings were revealed last month, Livio and the French eventing team were disqualified from the FEI World Equestrian Games 2014. As a result, France lost its slot in the Rio 2016 Olympic Games.

As well as a six-month ban on Livio, which came into effect on 7 May, the FEI Tribunal ordered the athlete to pay CHF 2,500 in addition to covering the costs of the B sample analysis and contributing to the judicial procedure costs.

Acepromazine is a controlled medication substance on the FEI prohibited substances list. The list comprises substances that are regularly used to treat horses but are prohibited in competitions to maintain a level playing field.

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
RCVS annual renewal fee for vets due

RCVS' annual renewal fee for veterinary surgeons is now due. Vets must pay their renewal fee before Wednesday, 1 April 2026.

This year's standard annual fee has increased to 431 from last year's 418. This is an approximately three per cent increase, as approved by RCVS Council and the Privy Council.

Tshidi Gardner, RCVS treasurer, said: "The small fee increase will be used to help deliver both our everyday activities and our new ambitious Strategic Plan, which includes aims such as achieving new legislation, reviewing the Codes of Professional Conduct and supporting guidance, and continuing to support the professions through activities such as the Mind Matters Initiative, RCVS Academy and career development."

A full breakdown of the new fees is on the RCVS website. Information about tax relief is available on the UK government website.